Companies:
49,447
Total Market Cap:
133961816285032.44
Ernexa Therapeutics
NASDAQ: ERNA
Healthcare
Biotechnology
Global Rank
#40325
Country Rank
#4913
Market Cap
9.52 M
Price
2.29
Change (%)
3.38%
Volume
107,871
Ernexa Therapeutics's latest marketcap:
9.52 M
As of 06/15/2025, Ernexa Therapeutics's market capitalization has reached $9.52 M. According to our data, Ernexa Therapeutics is the 40325th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 9.52 M |
| Revenue (ttm) | 535,000 |
| Net Income (ttm) | -46,110,000 |
| Shares Out | 4.16 M |
| EPS (ttm) | -26.98 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 06/20/2025 |
Market Cap Chart
Data Updated: 06/15/2025
Ernexa Therapeutics's yearly market capitalization.
Ernexa Therapeutics has seen its market value drop from $15.8 M to $9.52 M since 1998, representing a total decrease of 39.74% and an annual compound decline rate (CAGR) of 1.90%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/15/2025 | $9.52 M | -37.75% | 40325 |
| 12/31/2024 | $15.1 M | 55.67% | 35855 |
| 12/29/2023 | $9.7 M | 2.11% | 37220 |
| 12/30/2022 | $9.5 M | -95.62% | 36133 |
| 12/31/2021 | $217 M | 3187.88% | 18352 |
| 12/31/2020 | $6.6 M | 3.12% | 33293 |
| 12/31/2019 | $6.4 M | 14.29% | 2832 |
| 12/31/2018 | $5.6 M | -47.17% | 2837 |
| 12/29/2017 | $10.6 M | -44.79% | 2798 |
| 12/30/2016 | $19.2 M | 29.73% | 2664 |
Company Profile
Ernexa Therapeutics was founded in 2018 in United States.
on the Nasdaq Stock Market.
With 6 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Ernexa Therapeutics's (ERNA) current market cap?As of 06/15/2025, Ernexa Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $9.52 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Ernexa Therapeutics (ERNA) rank globally by market cap?Ernexa Therapeutics global market capitalization ranking is approximately 40325 as of 06/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.